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Abstract 
 
Gastrointestinal stromal tumors (GIST) because of its rarity continues to be a curiosity for radiologists, surgeons and 
pathologist. These tumors are usually found in gastrointestinal tract (GIT) but account for less than 1% of GIT 
tumors. A 35-year-old male presented to us with complaints of painful micturation which on radiologic evaluation 
revealed a large mass in relation to urinary bladder. The tru-cut biopsy reported a low grade soft tissue tumour. The 
said mass was excised on laparotomy and sent for histopathological examination which reported as high grade GIST 
or a pleomorphic sarcoma as possibilities. Immuno-histochemistry finally confirmed the diagnosis of a GIST with 
CD 34 positive and C-Kit negative status. Approximately, 95% of GIST tumors are C-Kit positive and hardly 5% are 
C-Kit negative. C-Kit negative status makes this case report more worth reporting. 
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Introduction 
 
Gastrointestinal stromal tumors (GIST) account for less 
than 1% of gastrointestinal tumors (GIT). GIST are 
usually seen in the stomach or small bowel. Amongst 
the mesenchymal tumors GIST is most commonly 
found in GIT (1). These tumors at times may come out 
of the confines of GIT and involve omentum, mesentery 
or retroperitoneum (2). GIST can behave as a benign or 
as a malignant tumor depending on the size and mitotic 
activity (3). The diagnosis of these lesions many a times 
may be quite difficult and it will be possible only after 
knowing the immune-phenotypic features and histology 
of the lesion. These tumors are rarely seen outside the 
GIT. 
 
 
 
 
 
 
 
 
Case Report 
 
A 35-year-old male without any past medical history 
presented with painful micturation since 3 months. 
Physical examination showed firm mass in 
hypogastrium measuring about 10x8 cm. 
Ultrasonography showed a well circumscribed 
hypoechoic mass uniform in echogenicity about 763 x 
95.6 x 80 mm with a volume of 324ml seen in relation to 
bladder and compressing right lateral wall of bladder. 
CECT abdomen and pelvis showed a heterogeneous mass 
seen in pelvis measuring 94x81 mm in size compressing 
urinary bladder. Exact origin of mass not clear on CT 
(Fig. 1). Impression was a GIST or a neural tumour  or 
any other connective tissue tumour. Tru-cut biopsy of 
lesion was reported a low grade soft tissue tumour of 
spindle cell morphology, and could not be categorised 
further. Patient was taken for surgical exploration and 
operative findings were a large tumour of size 10x15 cm 
retro pubic in position adherent to posterior wall of pubic 
symphysis and infiltrating  anterior wall of urinary 
bladder, tumour was firm to hard in consistency highly 
vascular, fleshy with areas of cavitations inside. Excision  
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Figure 1: CECT picture showed a heterogeneous mass seen in 
pelvis measuring 94x81 mm in size compressing urinary 
bladder (arrow). Exact origin of mass not clear on CT but 
tumor showing a close proximity with left sided pelvic bone 
and bladder wall. 
 
of pelvic mass along with anterior bladder wall with 
repair of urinary bladder was performed. Histopathology 
in multiple serial sections showed spindle cell 
neoplasm. The individual cells showed moderate 
pleomorphism, there are places of neural differentiation 
and diagnostic possibilities are GIST-high grade or 
pleomorphic sarcoma (Fig. 2). Paraffin block was revised 
which revealed GIST-high grade, and immune 
histochemistry of tumour was CD-34 positive and C-kit 
negative. On the basis of radiological, histopathology 
and immune-histochemistry GIST of pelvic wall was 
diagnosed. The post-operative period was smooth and 
patient is still on follow-up for more than 2 years with 
Department of Medical Oncology and General Surgery 
and has received imatanib mesylate one tablet daily as 
adjuvant therapy for two years. Follow-up 
investigations did not show any evidence of recurrence. 
 
Discussion 
 
GIST may present as a pelvic mass with extra intestinal 
origin; even though it is a rare occurrence but some 
cases with diagnostic dilemmas like our case have been 
reported in literature (4,5,6).  
 
Gastrointestinal stromal tumors may occur anywhere in 
GI tract including the stomach, small intestine, 
esophagus, rectum and colon. In rare cases, the 
gastrointestinal stromal tumor can occur at other 
locations in abdomen (7). The actual origin of GIST is a 
pluripotential mesenchymal stem cell. This cell was 
programmed to differentiate into the interstitial cell of  
 
 
 
 
Figure 2: High Grade GIST pleomorphic spindle cells (yellow 
arrows) and mitotic figures (red arrows) in a neural 
background. H&E-(10X) 
 
 
Cajal. These cells are believed to initiate and coordinate 
GI motility, hence the name GI pacemaker cells was 
coined by Kinblom and co workers (8). In subsequent 
years, research showed that Cajal cells are 
developmentally dependant on stem cell factor and 
express KIT which is regulated through KIT kinase. It 
was ultimately the work of Hirota et al. (9) in 1998 by 
discovering c-kit proto oncogene mutations in GIST and 
it was established as a separate entity. In present day 
time GIST is diagnosed on basis of histology, 
immunohistochemistry and oncogene c-kit mutation 
(10). Nowadays, based on histology, we can 
differentiate GIST from pleomorphic and spinde cell 
tumors. Approximately, 95% GIST tumors express C-
Kit (CD117) and 70% express CD 34. In addition 80% 
express heavy caldesmon and 25% are positive for 
smooth muscle actin and 5% for desmin (10). Somatic 
mutation may occur independent of anatomic location 
of the tumor and this mutation of CD 117 is observed in 
majority of GIST tumors (11).  
 
Conclusion 
 
This case proves that GIST can have a varied clinical 
presentation and can even arise from the pelvic wall as a 
huge mass with a C-kit negative status. It would be 
always wise to send immunohistochemistry in such 
doubtful histological variants to establish the diagnosis. 
Even such huge tumors with unusual presentations if 
followed properly and put on adjuvant treatment can 
respond well. 
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